Suppr超能文献

韩国卫生技术评估机构对卫生技术进行重新评估的审议过程。

Deliberative process of health technology reassessment by health technology assessment agency in Korea.

机构信息

Division of Healthcare Technology Assessment Research, National Evidence-based healthcare Collaborating Agency, Seoul, Republic of Korea.

Department of Neurosurgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.

出版信息

Int J Technol Assess Health Care. 2024 May 13;40(1):e28. doi: 10.1017/S026646232400014X.

Abstract

In 2019, the National Evidence-based Healthcare Collaborating Agency (NECA) in Korea established a health technology reassessment (HTR) system to manage the life cycle of health technologies and develop operational measures promoting the efficient use of healthcare resources. The purpose of this study is to introduce the detailed implementation process and practical functional methods of the HTR implemented by NECA.The HTR is a structured multidisciplinary method for analyzing health technologies currently used in the healthcare system based on the latest information on parameters, such as clinical safety, effectiveness, and cost-effectiveness of optimizing the use of healthcare resources as well as social and ethical issues. All decision-making stages of the HTR are carefully reviewed and transparently managed. The HTR committee makes significant decisions, and the subcommittee decides the details related to the assessment process.Since the pilot began in 2018, 262 cases have been reassessed, of which, 126 cases (48.1 percent) were health services not covered by the National Health Insurance (NHI). Over the past 5 years, approximately 130 recommendations for the in-use technologies were determined by the HTR committee. In the near future, it will be necessary to officially develop and establish a Korean HTR system and a legal foundation to optimize the NHI system.

摘要

2019 年,韩国国家循证医疗协作机构(NECA)建立了卫生技术再评估(HTR)系统,以管理卫生技术的生命周期,并制定促进高效利用卫生资源的运营措施。本研究旨在介绍 NECA 实施的 HTR 的详细实施过程和实用功能方法。HTR 是一种基于最新信息的结构化多学科方法,用于分析医疗系统中当前使用的卫生技术,这些信息包括临床安全性、有效性和成本效益,以及社会和伦理问题,以优化卫生资源的利用。HTR 的所有决策阶段都经过仔细审查和透明管理。HTR 委员会做出重大决策,小组委员会决定与评估过程相关的细节。自 2018 年试点开始以来,已有 262 个案例进行了重新评估,其中 126 个案例(48.1%)是国家健康保险(NHI)未涵盖的卫生服务。在过去的 5 年中,HTR 委员会确定了大约 130 项关于现有技术的建议。在不久的将来,有必要正式开发和建立韩国 HTR 系统和法律基础,以优化 NHI 系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0eda/11569900/8a86d9da90fe/S026646232400014X_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验